Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.60 +5.23 (+4.61%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
40 41 Next >
Why Abbott Laboratories Shares Are Trading Higher Today?
Via Benzinga
Abbott Labs Shakes Off Covid Test Decline To Top First-Quarter Estimates
Covid tests are still expected to bring in $1.5 billion in sales this year. 
Via Investor's Business Daily
2 Stocks That Could Help Make You a Millionaire by Retirement
These companies are accustomed to delivering excellent returns. 
Via The Motley Fool
Nasdaq, S&P Futures Falter As Mixed Earnings Weigh Down On Sentiment
Earnings continue to be front and center in the market, with futures trading signaling a negative start on Wednesday. More bellwether names are due to turn in their quarterly scorecard, potentially... 
Via Benzinga
Morgan Stanley, Tesla And 3 Stocks To Watch Heading Into Wednesday
With US futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
New York Rep. Daniel Goldman Sold Over $50K Worth of Abbott Laboratories Stock: Here's What You Should Know
Via Benzinga
A Preview Of Abbott Laboratories's Earnings
Via Benzinga
10 Analysts Have This to Say About Abbott Laboratories
Via Benzinga
Investor Optimism Declines Following Earnings Reports
The CNN Money Fear and Greed index showed some decline in overall sentiment among U.S. investors on Tuesday. U.S stocks closed mostly flat on Tuesday as investors digested the recent batch of earnings... 
Via Benzinga
Major Earnings Misses And Beats: Your Guide To This Week's Big Earnings In Play
We saw other large financial companies report their earnings along with stocks across other sectors miss or exceed expectations though the broader market was completely unchanged by the close. 
Via Talk Markets
Abbott Laboratories, National Retail Properties, UnitedHealth Group And A Big Bank Reporting Upbeat Earnings: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) 
Via Benzinga
Profit from the Artificial Intelligence Boom with These 7 AI ETFs
The artificial intelligence revolution is already here, creating a massive $1.81 trillion opportunity for AI ETFs. 
Via InvestorPlace
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
What's In Store For Abbott Laboratories In Q1 Earnings?
Abbott Laboratories is slated to report first-quarter 2023 results on Apr. 19 before the market opens. 
Via Talk Markets
3 No-Brainer Medical Device Stocks to Buy Right Now
These companies have consistently delivered revenue and EPS gains. 
Via The Motley Fool
3 Discounted Dividend Stocks With Combined 150+ Years Of Dividend Growth
All three of these dividend stocks have paid a growing dividend for more than 25 years each 
Via The Motley Fool
Better Dividend Stock: AbbVie vs. Johnson & Johnson
Both companies have a lot to offer income-seekers. 
Via The Motley Fool
3 Dividend-Growth Stocks to Buy in April That Can Crush Inflation
No need to worry about keeping up with inflation with these rapidly growing payouts. 
Via The Motley Fool
3 Healthcare Stocks to Watch As the Industry Evolves
Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services. 
Via InvestorPlace
2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever
Investors should buy the dips on these healthcare giants. 
Via The Motley Fool
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now
These two blue-chip dividend stocks offer investors a reliable income stream in a volatile market. 
Via The Motley Fool
Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage
House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Healthcare Stocks With at Least 30 Years of Dividend Increases
Among the many industry sectors to invest in, healthcare can be one of the most stable, especially regarding the dividend yield. 
Via MarketBeat
FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities
Via Benzinga
2 Top Dividend Stocks You Can Buy and Hold Forever
These two companies have been growing their payouts for more than a century combined. 
Via The Motley Fool
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Via Benzinga
Why The Apple Watch Comes Up Short In Heart Attack Detection… And Other Alternatives
While there can be some value in having a single-lead ECG always available, patients with known heart conditions need much better technology. 
Via Talk Markets
7 Dividend Kings to Buy for an Uncertain Market Environment
With so much turbulence in the global economy, these dividend kings to buy may help you weather the extreme storm. 
Via InvestorPlace
< Previous 1 2
...
14 15 16 17 18 19 20 21 22
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback